People who use cocaine, amphetamines at double suicide risk

People who use cocaine and amphetamines face almost two-fold greater risk of suicidal behaviour between people who inject drugs.

GSK hepatitis C shot shows promise, bodes well for Ebola vaccines

A new hepatitis C vaccine from GlaxoSmithKline based on the same technology as an experimental Ebola shot being fast-tracked through human trials has shown promise in early clinical tests, prompting strong and broad immune responses.

New 'miracle' drug eliminates Hepatitis C virus in up to 98 pc patients

Scientists have revealed that a new, which will be soon available on the NHS, has been shown to eliminate the virus per cent of patients.

Hepatitis C may become rare by 2036: Study

The deadly hepatitis C could become a rare disease by the year 2036 owing to new effective drugs and widespread screening, says a study.

New combination of pills curing hepatitis C patients revealed

A new study has revealed a combination of pills that cures 9 of 10 hepatitis C patients and is well tolerated by patients.

Forget injection, pills to cure hardest-to-treat hepatitis C

On this World Hepatitis Day, there`s good news for patients, particularly from India, for those suffering from hepatitis C.

India has the second highest number of Hepatitis B infected

India has over 40 million Hepatitis B infected patients, second only to China, and most people with chronic Hepatitis B or C are unaware of their infection, putting them at serious risk of developing cirrhosis or liver cancer which are life threatening.

Lack of blood screening causing Hepatitis C

Vardhan Singh, a 65-year-old patient of acute anaemia, met with an accident 25 years ago. The grievous injuries he suffered and the loss of blood compelled doctors to transfuse extra blood to his body.

New drug cures Hepatitis C in HIV patients

In a ray of hope for patients infected with both HIV and Hepatitis C, researchers have found that a combination drug therapy cures chronic Hepatitis C in majority of such patients.

Simple blood tests can save hepatitis patients

Blood tests can save more than 80 percent hepatitis C patients and over 60 percent hepatitis B patients when combined with proper prevention and treatment, say experts.

Need to address Hepatitis C, drug use: Experts

There was an urgent need to address issues like Hepatitis-C and adolescent drug use to prevent spread of HIV/AIDS, experts said Tuesday.

New combination of drug therapy could help treat Hepatitis C

Scientists have a new combination drug therapy that can effectively treat Hepatitis C.

Merck`s hepatitis C drugs show 98% cure rate in trial

Offering new hopes to millions of people infected with Hepatitis C, a two-drug combination by Merck & Co to treat the infectious liver disease has showed a cure rate of 98% in a mid-stage trial.

Researchers claim breakthrough in HIV,Hepatitis C with DNA vaccine

In a significant breakthrough by Australian scientists, a new type of DNA vaccine can help in tackling HIV and Hepatitis C.

New drug combo cures toughest cases of hepatitis C

A pair of experimental, oral antiviral drugs are safe and highly effective in the treatment of hepatitis C, a liver-damaging infectious disease, scientists have found.

New drug combo cures toughest cases of hepatitis C

A pair of experimental, oral antiviral drugs are safe and highly effective in the treatment of hepatitis C, a liver-damaging infectious disease, scientists have found.

Hepatitis C: All that you need to know about the silent killer

According to the World Health Organisation (WHO), about 150 million people are chronically infected with hepatitis C virus, and more than 350,000 people die yearly from hepatitis C-related liver diseases.

US approves breakthrough drug for hepatitis C

US has approved a breakthrough therapy for treatment of chronic hepatitis C that is expected to offer a more palatable cure to millions of people infected with the liver-destroying viral disease.

New breakthrough brings `effective` hepatitis C cure closer to reality

Researchers have determined the most detailed picture yet of a crucial part of the hepatitis C virus, which the virus uses to infect liver cells.

FDA panel backs Gilead hepatitis C drug sofosbuvir

A federal advisory panel recommended on Friday that the U.S. Food and Drug Administration approve Gilead Sciences Inc`s experimental hepatitis C drug sofosbuvir.